Arena Pharmaceuticals Inc

Most Recent

  • Arena Pharmaceuticals Care More, Act Differently
    Company & Industry Overviews

    Arena Pharmaceuticals' Pipeline Includes Bowel Disease Treatments

    With Pfizer poised to acquire Arena Pharmaceuticals, the drug company's pipeline comes into question. What's Arena developing?
    By Rachel Curry
  • uploads///cannabis _
    Company & Industry Overviews

    Cannabis Stocks Had a Mixed Performance Last Week

    Cannabis ETFs traded on a largely negative note last week.

    By Mohit Oberoi, CFA
  • uploads///part
    Company & Industry Overviews

    Key Cannabis Sector Updates: Analyst Ratings and Earnings

    Last week, Emerald Health Therapeutics (EMH) closed with losses of 9.4%.

    By Mohit Oberoi, CFA
  • uploads///Graph
    Company & Industry Overviews

    Semaglutide May Prove to Be an Effective Anti-Obesity Therapy

    Novo Nordisk plans to initiate its Phase 3a program, STEP, to study the efficacy of 2.4 mg of semaglutide once per week in obesity indications in 1H18.

    By Margaret Patrick
  • uploads///doctor _
    Company & Industry Overviews

    Saxenda May Continue to Lead in the Diabetes Segment in 2018

    In 2017, Novo Nordisk’s (NVO) Saxenda sales reached 2.6 billion Danish kroner, a YoY (year-over-year) rise of 64%.

    By Margaret Patrick
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.